Substituted oxazolidinones and their use in the field of blood coagulation

Details for Australian Patent Application No. 2004218729 (hide)

Owner Bayer HealthCare AG

Inventors Not Given

Agent Davies Collison Cave

Pub. Number AU-A-2004218729

Parent 775126

Filing date 13 October 2004

Wipo publication date 4 November 2004

International Classifications

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 007/00 Drugs for disorders of the blood or the extracellular fluid

A61K 031/42 - Oxazoles

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

28 October 2004 Complete Application Filed

4 November 2004 Application Open to Public Inspection

  Published as AU-A-2004218729

23 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218730-A teat cup carrier

2004218728-Stable salts of O-acetylsalicyclic acid with basic amino acids